Atlas Trials

Study of Gemcitabine and Abraxane for Pancreas Cancer

Clinical trial NCT02242409 · TERMINATED

Trial details

NCT number
NCT02242409
Sponsor
Georgetown University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2014-09-01
Primary completion
2016-12-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.